Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 43386-480

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 43386-480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)

Chemical structure diagram of orphenadrine citrate, showing the molecular composition of its active ingredients.*

FDA Label Image

Lupin Symbol (Lupin Symbol Pic)

ORPHENADRINE CITRATE 100 mg extended-release oral tablets packaging from Lupin Pharmaceuticals, Inc. The carton contains 30 tablets. The front label displays the product name, strength, and dosage form.*

FDA Label Image

100 Ct (Figure 1)

Label for Orphenadrine Citrate Extended-Release Tablets, 100 mg strength, oral dosage form. The label shows a bottle containing 1000 tablets and states Rx only. Manufactured by Novel Laboratories, Inc. and labeled for Lupin Pharmaceuticals, Inc. Storage instructions and a warning to keep out of children's reach are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.